Literature DB >> 19442046

Mechanisms of drug sensitivity and resistance in cancer.

Lorraine O'Driscoll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19442046     DOI: 10.2174/156800909788166510

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


× No keyword cloud information.
  4 in total

1.  Proflavin suppresses the growth of human osteosarcoma MG63 cells through apoptosis and autophagy.

Authors:  Mao-Shu Zhang; Fu-Wen Niu; Kun Li
Journal:  Oncol Lett       Date:  2015-05-14       Impact factor: 2.967

2.  Knockdown of Rad51 expression induces radiation- and chemo-sensitivity in osteosarcoma cells.

Authors:  Li-Qing Du; Yong Wang; Hong Wang; Jia Cao; Qiang Liu; Fei-Yue Fan
Journal:  Med Oncol       Date:  2010-07-13       Impact factor: 3.064

3.  Secretory prostate apoptosis response (Par)-4 sensitizes multicellular spheroids (MCS) of glioblastoma multiforme cells to tamoxifen-induced cell death.

Authors:  Jayashree C Jagtap; D Parveen; Reecha D Shah; Aarti Desai; Dipali Bhosale; Ashish Chugh; Deepak Ranade; Swapnil Karnik; Bhushan Khedkar; Aaishwarya Mathur; Kumar Natesh; Goparaju Chandrika; Padma Shastry
Journal:  FEBS Open Bio       Date:  2014-11-21       Impact factor: 2.693

4.  DOX-Vit D, a Novel Doxorubicin Delivery Approach, Inhibits Human Osteosarcoma Cell Proliferation by Inducing Apoptosis While Inhibiting Akt and mTOR Signaling Pathways.

Authors:  Zaid H Maayah; Ti Zhang; Marcus Laird Forrest; Samaa Alrushaid; Michael R Doschak; Neal M Davies; Ayman O S El-Kadi
Journal:  Pharmaceutics       Date:  2018-09-04       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.